Regencell Bioscience Holdings (RGC) Short-term Investments (2022 - 2025)

Regencell Bioscience Holdings (RGC) has 4 years of Short-term Investments data on file, last reported at $2.5 million in Q2 2025.

• Quarterly Short-term Investments fell 50.44% year-over-year to $2.5 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $2.5 million (down 50.44% YoY) and the FY2025 annual result came in at $2.5 million, down 50.44% from the prior year.
• Short-term Investments fell to $2.5 million in Q2 2025, from $5.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $10.0 million in Q2 2022 to a low of $2.5 million in Q2 2025.
• A 4-year average of $6.9 million and a median of $7.5 million in 2022 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2023 — Short-term Investments changed 0.0% — and 2025, when it plunged 50.44%.
• Tracing RGC's Short-term Investments over 4 years: stood at $10.0 million in 2022, then changed by 0.0% to $10.0 million in 2023, then slumped by 50.0% to $5.0 million in 2024, then sank by 50.44% to $2.5 million in 2025.
• The last three Short-term Investments figures came in at $2.5 million (Q2 2025), $5.0 million (Q2 2024), and $10.0 million (Q2 2023), per Business Quant data.